Form 4: Natera Executive Solomon Moshkevich Sells Shares to Cover Tax Obligations

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 549 shares of common stock on July 22, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Summary

• On July 22, 2024, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 549 shares of common stock.
• The sale was executed to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
• The transaction was conducted under a pre-arranged written instruction intended to comply with Rule 10b5-1(c) of the Exchange Act.
• The shares were sold at a weighted average price of $105.1597.
• The prices for individual transactions ranged from $104.9850 to $105.16 per share.
• Following the transaction, Moshkevich directly owns 113,637 shares of Natera, Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and executed under a pre-arranged plan, so it doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations related to vesting equity compensation. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on current market information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided mitigates this concern.

Key Dates